{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:35:48Z","timestamp":1779935748951,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.amepre.2022.09.013","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T02:02:45Z","timestamp":1671069765000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chronic and Sustained High-Dose Opioid Use in an Integrated Health System"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8684-6506","authenticated-orcid":false,"given":"Rulin C.","family":"Hechter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig K.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fagen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6395-8046","authenticated-orcid":false,"given":"Deborah S.","family":"Ling Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna L.","family":"Barreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6491-7745","authenticated-orcid":false,"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.amepre.2022.09.013_bib0001","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1155\/2011\/465281","article-title":"A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain","volume":"16","author":"Furlan","year":"2011","journal-title":"Pain Res Manag"},{"issue":"11","key":"10.1016\/j.amepre.2022.09.013_bib0002","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1503\/cmaj.051528","article-title":"Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects","volume":"174","author":"Furlan","year":"2006","journal-title":"CMAJ"},{"issue":"4","key":"10.1016\/j.amepre.2022.09.013_bib0003","doi-asserted-by":"crossref","first-page":"295","DOI":"10.7326\/M14-2775","article-title":"National Institutes of Health Pathways to Prevention Workshop: the role of opioids in the treatment of chronic pain","volume":"162","author":"Reuben","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.amepre.2022.09.013_bib0004","article-title":"Long-term opioid management for chronic noncancer pain","volume":"2010","author":"Noble","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.amepre.2022.09.013_bib0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7326\/ACPJC-2006-145-3-074","article-title":"Review: opioids are more effective than placebo but not other analgesics for chronic noncancer pain","volume":"145","author":"Carey","year":"2006","journal-title":"ACP J Club"},{"issue":"4","key":"10.1016\/j.amepre.2022.09.013_bib0006","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/AJP.0b013e31802b582f","article-title":"Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study","volume":"23","author":"Portenoy","year":"2007","journal-title":"Clin J Pain"},{"issue":"10","key":"10.1016\/j.amepre.2022.09.013_bib0007","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s40263-019-00660-0","article-title":"Opioid-induced tolerance and hyperalgesia","volume":"33","author":"Mercadante","year":"2019","journal-title":"CNS Drugs"},{"issue":"suppl 1","key":"10.1016\/j.amepre.2022.09.013_bib0008","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1111\/pme.12914","article-title":"Opioid induced hyperalgesia","volume":"16","author":"Yi","year":"2015","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.amepre.2022.09.013_bib0009","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13181-012-0260-0","article-title":"Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesia","volume":"8","author":"Brush","year":"2012","journal-title":"J Med Toxicol"},{"issue":"7","key":"10.1016\/j.amepre.2022.09.013_bib0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/AJP.0000000000000021","article-title":"The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription","volume":"30","author":"Edlund","year":"2014","journal-title":"Clin J Pain"},{"issue":"11","key":"10.1016\/j.amepre.2022.09.013_bib0011","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/pme.12480","article-title":"Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients","volume":"15","author":"Zedler","year":"2014","journal-title":"Pain Med"},{"issue":"13","key":"10.1016\/j.amepre.2022.09.013_bib0012","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2022.09.013_bib0013","series-title":"Opioid prescriptions decrease for 10th consecutive year","year":"2021"},{"issue":"6","key":"10.1016\/j.amepre.2022.09.013_bib0014","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2013United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.amepre.2022.09.013_bib0015","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/add.14878","article-title":"The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States","volume":"115","author":"Hoots","year":"2020","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.amepre.2022.09.013_bib0016","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s11606-019-05545-y","article-title":"Risk of overdose with exposure to prescription opioids, benzodiazepines, and non-benzodiazepine sedative-hypnotics in adults: a retrospective cohort study","volume":"35","author":"Cho","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"7","key":"10.1016\/j.amepre.2022.09.013_bib0017","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MLR.0000000000000738","article-title":"Patterns of opioid use and risk of opioid overdose death among Medicaid patients","volume":"55","author":"Garg","year":"2017","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.amepre.2022.09.013_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"10.1016\/j.amepre.2022.09.013_bib0019","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.16860","article-title":"Changes in initial opioid prescribing practices after the 2016 release of the CDC guideline for prescribing opioids for chronic pain","volume":"4","author":"Goldstick","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.amepre.2022.09.013_bib0020","first-page":"1352","article-title":"Association of 3 CDC opioid prescription guidelines for chronic pain and 2 payer pharmacy coverage changes on opioid initiation practices","volume":"27","author":"Togun","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"10.1016\/j.amepre.2022.09.013_bib0021","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.11826","article-title":"Association of the 2016 U.S. Centers for Disease Control and Prevention opioid prescribing guideline with changes in opioid dispensing after surgery","volume":"4","author":"Sutherland","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.amepre.2022.09.013_bib0022","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/jep.12756","article-title":"Safer and more appropriate opioid prescribing: a large healthcare system's comprehensive approach","volume":"23","author":"Losby","year":"2017","journal-title":"J Eval Clin Pract"},{"issue":"3","key":"10.1016\/j.amepre.2022.09.013_bib0023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7812\/TPP\/12-031","article-title":"Sociodemographic characteristics of members of a large, integrated health care system: comparison with U.S. Census Bureau data","volume":"16","author":"Koebnick","year":"2012","journal-title":"Perm J"},{"issue":"6","key":"10.1016\/j.amepre.2022.09.013_bib0024","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"De facto long-term opioid therapy for noncancer pain","volume":"24","author":"Von Korff","year":"2008","journal-title":"Clin J Pain"},{"issue":"11","key":"10.1016\/j.amepre.2022.09.013_bib0025","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jpain.2008.06.002","article-title":"Trends in use of opioids by noncancer pain type 2000\u20132005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study","volume":"9","author":"Braden","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.amepre.2022.09.013_bib0026","series-title":"Data resources","year":"2021"},{"key":"10.1016\/j.amepre.2022.09.013_bib0027","series-title":"Calculating total daily dose of opioids for safer dosage","year":"2021"},{"key":"10.1016\/j.amepre.2022.09.013_bib0028","series-title":"Racial\/ethnic differences in substance use, substance use disorders, and substance use treatment utilization among people aged 12 or older (2015\u20132019)","year":"2021"},{"issue":"4","key":"10.1016\/j.amepre.2022.09.013_bib0029","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"10.1016\/j.amepre.2022.09.013_bib0030","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1365-2753.2010.01504.x","article-title":"Applying a propensity score-based weighting model to interrupted time series data: improving causal inference in programme evaluation","volume":"17","author":"Linden","year":"2011","journal-title":"J Eval Clin Pract"},{"issue":"11","key":"10.1016\/j.amepre.2022.09.013_bib0031","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16271","article-title":"Trends and rapidity of dose tapering among patients prescribed long-term opioid therapy, 2008-2017","volume":"2","author":"Fenton","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.amepre.2022.09.013_bib0032","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13431","article-title":"Assessment of opioid prescribing patterns in a large network of U.S. community health centers, 2009 to 2018","volume":"3","author":"Muench","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.amepre.2022.09.013_bib0033","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11606-005-0105-5","article-title":"Racial differences in opioid use for chronic nonmalignant pain","volume":"20","author":"Chen","year":"2005","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.amepre.2022.09.013_bib0034","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1526-4637.2011.01310.x","article-title":"Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States","volume":"13","author":"Meghani","year":"2012","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.amepre.2022.09.013_bib0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMsa2034159","article-title":"Racial inequality in prescription opioid receipt\u2013role of individual health systems","volume":"385","author":"Morden","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amepre.2022.09.013_bib0036","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention's 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amepre.2022.09.013_bib0037","doi-asserted-by":"crossref","first-page":"m283","DOI":"10.1136\/bmj.m283","article-title":"Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in U.S. veterans: observational evaluation","volume":"368","author":"Oliva","year":"2020","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.amepre.2022.09.013_bib0038","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.amepre.2022.09.013_bib0039","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.9191","article-title":"Association of opioid dose reduction with opioid overdose and opioid use disorder among patients receiving high-dose, long-term opioid therapy in North Carolina","volume":"5","author":"Diprete","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amepre.2022.09.013_bib0040","series-title":"California\u2019s Prescription Drug Monitoring Program (PDMP)","year":"2022"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074937972200472X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074937972200472X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:07:37Z","timestamp":1760083657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074937972200472X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S074937972200472X"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2022.09.013","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic and Sustained High-Dose Opioid Use in an Integrated Health System","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2022.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}